Sirnaomics Ltd. (02257.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 3.77

From 52W high−80.82%

Volume200500.00

Market capHKD 358.00M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataSep 18, 2026

Open

HKD 3.77

From 52W high

−80.82%

Volume

200500.00

Market cap

HKD 358.00M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−3.9x

P/E (TTM)

—

RSI (14)

43.1

MomentumView details →

1D Return

−1.43%

YTD Return

−50.59%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−3.9x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

−7.5x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

175.39%

ROA (TTM)

−79.27%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

−100.00%

EPS YoY

+35.90%

FCF YoY

+1.65%

Revenue CAGR 3Y

−100.00%

EPS CAGR 3Y

+77.27%

EBITDA YoY

+19.96%

MomentumView details →

1D Return

−1.43%

YTD Return

−50.59%

1Y Return

−76.85%

RSI (14)

43.1

vs 50D SMA

−6.19%

vs 200D SMA

−38.22%

Capital & dividendView details →

Debt/Equity

−4.17x

Current Ratio

0.26x

Quick Ratio

0.26x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

HKD 0.01

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

949000.00

Net Income (TTM)

−24.65M

Op. CF (TTM)

−18.36M

Next earningsApr 1, 2027 →

Latest newsMore news →

Sirnaomics announced that its indirect non-wholly owned subsidiary RNAimmune will introduce Guangzhou Guangjian Pharmaceutical Innovation Equity Investment Fund Partnership as a strategic investor, injecting RMB 30 million into Damian Vaccine (Guangzhou) for a 5.66% stake.25d ago

Sirnaomics Ltd and its wholly-owned subsidiary Sirnaomics (Hong Kong) Limited filed a writ of summons in the High Court of the Hong Kong Special Administrative Region against several former management members, including Lu Yang, Dai Xiaochang, and Ye Yongji, over an investment of approximately US$20 million in an independent portfolio of TradArt Flagship Investment SPC.35d ago

Similar companies

Shanghai Bio-heart Biological Technology Co., Ltd.02185.HK Ocugen, Inc.OCGN Enanta Pharmaceuticals, Inc.ENTA X4 Pharmaceuticals, Inc.XFOR Agenus Inc.AGEN Orchestra BioMed Holdings, Inc.OBIO Find similar companies →

Latest newsMore news →

Sirnaomics announced that its indirect non-wholly owned subsidiary RNAimmune will introduce Guangzhou Guangjian Pharmaceutical Innovation Equity Investment Fund Partnership as a strategic investor, injecting RMB 30 million into Damian Vaccine (Guangzhou) for a 5.66% stake.25d ago Sirnaomics Ltd and its wholly-owned subsidiary Sirnaomics (Hong Kong) Limited filed a writ of summons in the High Court of the Hong Kong Special Administrative Region against several former management members, including Lu Yang, Dai Xiaochang, and Ye Yongji, over an investment of approximately US$20 million in an independent portfolio of TradArt Flagship Investment SPC.35d ago